| Document |
Document Title |
|
WO/2006/089251 |
Methods are provided herein for synergistically affecting tumor growth in a subject, involving the administration to the subject of an agent that blocks the TGF- β signaling pathway in combination with an immunogenic agent. The agent th...
|
|
WO/2006/085517 |
Ointment preparations based on a chlorin derivative or porphyrin derivative, for use in photodynamic therapy (PDT) applicable to skin diseases, such as solar keratosis, inflammatory keratosis, wart and epidermal cancer. There are provide...
|
|
WO/2006/080424 |
It is intended to produce a dairy product for treatment of milk allergy or a dairy product for prevention of onset of milk allergy by reducing the allergenicity of whey components, particularly β-lactoglobulin protein that has the highe...
|
|
WO/2006/080243 |
Coated magnetic particle containing preparations that are capable of selective delivery (targeting potency) to a tumor region, and that not only can find application in contrast materials and drug carriers but also can be used in thermot...
|
|
WO/2006/075678 |
Disclosed is a novel photosensitive compound which is useful for photodynamic therapy. Also disclosed are an agent for photodynamic therapy which contains such a photosensitive compound, and a method for producing such a photosensitive c...
|
|
WO/2006/073333 |
The invention relates to pharmaceuticals, biological physics and biodiagnostics, more specifically to preparations producing a magnetoresonance action on micro- and macro-organisms for increasing and protecting the life activity thereof ...
|
|
WO/2006/068187 |
It is intended to provide a means of inactivating a target physiological function by forming active oxygen depending on light irradiation. Namely, it is intended to provide a target physiological function inactivator characterized by com...
|
|
WO/2006/064205 |
Processes are disclosed for the preparation of a compound having the formula: (I) and intermediate compounds wherein M is a single-photon-emission tomography imageable radiometal and/or a paramagnetic metal, R is hydrogen or a halogen pr...
|
|
WO/2006/064205 |
Processes are disclosed for the preparation of a compound having the formula: (I) and intermediate compounds wherein M is a single-photon-emission tomography imageable radiometal and/or a paramagnetic metal, R is hydrogen or a halogen pr...
|
|
WO/2006/056227 |
The present invention relates to a peptide conjugate that is useful in diagnostics and therapy, to the use of said conjugate for preparing a diagnostic or therapeutic composition or a composition for the observation of the functioning of...
|
|
WO/2006/053707 |
The invention relates to derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, having formula (I) and (II), which can be used in photodynamic therapy. According to the invention, X1, X2, X3, X4, X5, X6, X7, X8, which m...
|
|
WO/2006/051732 |
A pharmaceutical preparation containing coated magnetic particles, wherein magnetic particles being chemically bonded to an organic compound having, in the molecule thereof, at least two pieces of groups selected from among a hydroxyl gr...
|
|
WO/2006/051198 |
The invention relates to novel activatable particles which can be used in the health field. More specifically, the invention relates to composite nanoparticles comprising an intracellular targeting element, which can generate a response ...
|
|
WO/2006/048633 |
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particular...
|
|
WO/2006/048633 |
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particular...
|
|
WO/2006/047868 |
Method and kit for treating microorganisms in the oral cavity. Such microorganisms include those which contribute to periodontal disease and halitosis. The method comprises the steps of applying a photosensitizer to the interior of the m...
|
|
WO/2006/047080 |
Embodiments of the present invention relate to methods and pharmacological compositions to treat presbyopia in the human eye. According to the embodiments, pharmacological compositions may be applied to an eye to effect a change in the a...
|
|
WO/2006/041617 |
Polymers comprising a polyethylenimine, a biodegradable group, and a relatively hydrophobic group are useful for the delivery of bioactive agents to cells.
|
|
WO/2006/041670 |
A method of treating or preventing osteolysis, comprising the steps of : a) providing a implant having a UVB light source, b) positioning the implant within or adjacent to an osteolytic region adjacent an orthopedic implant, and c) activ...
|
|
WO/2006/036176 |
Methods of treating diseases of a subject through selective occlusion of blood vessels. The methods include identifying and/or mapping the blood vessels supplying nutrients to the diseased or unwanted tissue, delivering an appropriate do...
|
|
WO/2006/026853 |
The present invention provides the use of Z. americanum OR Z. clava-herculis tissue for the preparation of antival agents. The invention also provides a composition for use in treating a viral infection comprising a pyranocoumarin enrich...
|
|
WO/2006/027582 |
Disclosed is a polymer comprising covalently bound side chains of the formula -X-Y-Z-R wherein X is a spacer group; is a sulphur, selenium or tellurium atom; Z is a sulphur, selenium or tellurium atom any of which may be bonded to one or...
|
|
WO/2006/022340 |
A temperature-responsive polymer (a hydrated graft structure) layer (2) comprising an acrylamide derivative or the like, which develops highly temperature-responsive properties, is covalently immobilized on magnetic fine particles (1) fo...
|
|
WO/2006/020979 |
Methods and compositions are provided for the treatment of diseases such as exudative macular degeneration, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, retinal neovascularization, iris neovascularizati...
|
|
WO/2006/015493 |
A method of treating mammalian skin tissues for causing a predetermined physiological change in the mammalian skin tissues. A treatment composition of matter is applied onto the mammalian skin. The mammalian skin is irradiated with a fir...
|
|
WO/2006/015016 |
The invention provides a photodynamic therapy-based method for treating ocular glaucoma. A photosensitizer, for example, a benzoporphyrin derivative photosensitizer, is administered to a mammal either having or at risk of developing ocul...
|
|
WO/2006/013227 |
|
|
WO/2006/012752 |
The invention is directed to a therapy device, including a body, an energy source disposed on the body for emitting a desired wavelength of electromagnetic radiation, and a material dispensing system disposed on the body for dispensing a...
|
|
WO/2006/012359 |
Methods are provided for inducing differentiation of blood monocytes into functional antigen presenting dendritic cells. The blood monocytes are treated by subjecting the monocytes to physical perturbation. The monocytes may be treated, ...
|
|
WO/2006/012359 |
Methods are provided for inducing differentiation of blood monocytes into functional antigen presenting dendritic cells. The blood monocytes are treated by subjecting the monocytes to physical perturbation. The monocytes may be treated, ...
|
|
WO/2006/012140 |
The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-cont...
|
|
WO/2006/012264 |
Guanylin cyclase C compound of the inventions are disclosed. Conjugated compounds comprising guanylin cyclase C compound of the inventions conjugated to detectable or therapeutic moieties are disclosed. Methods of detecting, imaging and ...
|
|
WO/2006/007261 |
Compositions of dendrimer-photosensitizer complexes including therapeutic molecules, and methods for their synthesis and use are disclosed. The therapeutic molecules and the photosensitizers are each covalently attached to the dendrimer ...
|
|
WO/2006/005971 |
This invention is based on the in situ conversion by photo-induced dehydrocyclization of organic molecules characterised by small aromatic surface (which do not intercalate into DNA and are biologically low active or inactive) into produ...
|
|
WO/2006/003463 |
The present application relates to a method for introducing a PNA molecule into the cytosol, preferably the nucleus of a cell, comprising contacting said cell with a PNA molecule and a photosensitising agent, and irradiating the cell wit...
|
|
WO/2006/003305 |
The invention relates to the field of wave transducers for medical or cosmetic use. More particularly the invention concerns an ultrasonic wave transducer for fast permeabilization of the skin to enable variable-weight active molecules t...
|
|
WO/2005/123105 |
The invention discloses various phototoxic compounds which include a photosensitizer conjugated to a peptide or peptoid. Additionally, the invention discloses a method of making and using the various phototoxic compound. Furthermore, the...
|
|
WO/2005/120573 |
The invention provides cationic tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one positively charged group and/or at least one basic group that is converted to a positively charged group under ph...
|
|
WO/2005/120590 |
The invention relates to activatable novel particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X-rays. The invention al...
|
|
WO/2005/120572 |
The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemu...
|
|
WO/2005/117976 |
A method for increasing or monitoring apoptosis in tumor cells by the co-administration of ionizing radiation and an anti-integrin antibody. Increasing apoptosis reduces tumor growth in vivo and in a cell culture model. The antibody is d...
|
|
WO/2005/115317 |
The invention provides a novel association of polyvinylpyrrolidone with chlorin p6 and/or its salt with a pharmaceutically acceptable counter-ion and a process for the preparation thereof. The association can be used as a photosensitizer...
|
|
WO/2005/115460 |
The invention provides a method of producing polypeptides from plant protein by using alternating high frequency high voltage electromagnetic field. The method comprises: making plant materials move in processing cavity, applying alterna...
|
|
WO/2005/110495 |
A bio-molecular contrast agent (BMCA) is introduced into a biological organism such that the agent binds or reacts with target tissue within that organism. The BMCA is also signalgiving, allowing control of particle beam therapy by tra...
|
|
WO/2005/110395 |
Disclosed are methods of positioning a magnetic drug carrier particle within the body of a subject comprising placing an article within the body of the subject or external to the body of a subject; inserting a magnetic drug carrier parti...
|
|
WO/2005/110397 |
The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment and/or prevention of myopia. An activating energy...
|
|
WO/2005/110365 |
A method for treating a posterior ocular condition so as to improve vision is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory component and a bioerodible polymeric com...
|
|
WO/2005/107701 |
The present invention relates to a method for remote control release of encapsulated substances by external forces such as ultrasound or light.
|
|
WO/2005/105181 |
A method and medical device for generating transient bubbles is provided. Fluid is delivered under pressure through bubble generating means and thereby transient bubbles are generated. The bubbles are micro or nano sized. An ultrasonic s...
|
|
WO/2005/105119 |
The invention relates to 5-aminosalicylic acid of slow- released type in magnetic intercalated structure and the preparation method thereof. The invention has NFe204 of spinel type as magnetic material, LDHs of anion layered material as ...
|
